Normal Saline for Parenteral Use Market Size (2023-2031) Share, Industry Trends, Growth, Challenges, and Forecast: Growth Plus Reports

Newark, New Castle, USA, July 03, 2023 (GLOBE NEWSWIRE) — As per the report by Growth Plus Reports, the normal saline for parenteral use market was valued at US$ 3.28 billion in 2022 and is expected to reach US$ 5.32 billion, registering a revenue CAGR of 5.5% by 2031.

The global market for the global normal saline for parenteral use market was analyzed, and it is expected to increase significantly during the forecast period. Normal saline is frequently used to treat various illnesses, including dehydration, electrolyte imbalance, wound care, sepsis, hemorrhage, and others.

Recent Development in the Global Normal Saline for Parenteral Use Market: 

• In February 2022, the US Food and Drug Administration gave B. Braun Medical clearance to start up operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida. 

Download the Free Sample Report Now @ https://www.growthplusreports.com/inquiry/request-sample/normal-saline-for-parenteral-use-market/8616

                            Normal Saline for Parenteral Use Market Scope

Key Takeaways: 

• The large prevalence of diseases requiring hospitalization is driving the global market revenue.
• The rising technical advancements and increasing investments in R&D are boosting revenue growth. 
• The rapid and most effective way to give diarrheal patients the fluids they need to stay alive is through parenteral administration of normal saline.

Market Drivers and Restraints: 

The demand for normal saline for parenteral use is rising as a result of increase in hospital admissions to ICUs and NICUs. This further contributed to the market revenue growth.

However, the replacement of saline with balanced fluids may limit the market revenue expansion. 

Market Segmentation: 

Segmentation By Type

Based on the type, the global normal saline for parenteral use market is segmented into plastic bottles, glass bottles, and flexible bags. The software segment accounts for the largest market revenue share due to the increasing use of strategic partnerships and the preference for plastic bottles over the glass to prevent breakage during the delivery of IV fluids. 

Segmentation By Application

Based on the application, the global normal saline for parenteral use market is segmented into intravascular injection, intravenous injection, and others. The intravenous segment accounts for the largest revenue share in the global market. Intravenous injection is the preferred way of delivering normal saline, which mostly accounts for the segment’s dominance.

Regional Growth Dynamics

Based on the region, the global normal saline for parenteral use market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The presence of significant key market players, high frequency of disease occurrence, and high disposable income contribute to the significant revenue share.

Request for Customization –https://www.growthplusreports.com/inquiry/customization/normal-saline-for-parenteral-use-market/8616

Competitive Landscape

The following is a list of the prominent players in the global market of normal saline for parenteral use: 

• Otsuka Pharmaceutical Co., Ltd.
• Kelun Group 
• ICU Medical 
• Double-Crane Pharmaceutical Co., Ltd. 
• B. Braun Melsungen AG

Report Coverage 

The global market for normal saline for parenteral use is studied and analyzed in-depth. The study looks at the basic market characteristics, significant investment opportunities, analytics of regional growth, revenue forecasting, significant market participants, and collaborations. 

Table of Content

1. INTRODUCTION

1. 1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report

2. RESEARCH METHODOLOGY 

2. 1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions

3. PREMIUM INSIGHTS

3. 1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape

4. MARKET DYNAMICS

4. 1. Drivers
   2. Restraints/Challenges
   3. Opportunities

5. GLOBAL NORMAL SALINE FOR PARENTERAL USE MARKET – ANALYSIS & FORECAST, BY PRODUCT TYPE

5. 1. Plastic Bottles
   2. Glass Bottles
   3. Flexible Bags

6. GLOBAL NORMAL SALINE FOR PARENTERAL USE MARKET – ANALYSIS & FORECAST, BY APPLICATION

6. 1. Intravascular Injection
   2. Intravenous Injection
   3. Others

NORMAL SALINE FOR PARENTERAL USE MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8616

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Combination Antihypertensives Market by Type (ACE Inhibitors with Calcium Channel blocking agents, ACE inhibitors with thiazides), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Hydatid Disease Treatment Market by Drug (Mebendazole, Albendazole), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

High-Grade Neuroendocrine Neoplasms Market by Drug Class (Platinum Coordination Complexes, Somatostatin Analogues), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Postoperative Pain Medication Market by Drug Class (NSAIDS, Opioids), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Mast Cell Stabilizers Market by Type (Mastocytosis, Seasonal Allergic Rhinitis, and Perennial Allergic Conjunctivitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook and Forecast 2023-2031

Unleashing the Power of Innovation in Med Tech:  https://growthplusmedtechroundup.com

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.